| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/19/2007 | US20070087960 Treating hepatitis C virus infections; antivirals have low toxicity to the host; inhibit Flaviviridae polymerase |
| 04/19/2007 | US20070087959 Method of inducing biomineralization method of inducing bone regeneration and methods related thereof |
| 04/19/2007 | US20070087958 Compounds and compositions for delivering active agents |
| 04/19/2007 | US20070087957 Methods and compositions for oral administration of proteins |
| 04/19/2007 | US20070087414 Uses of human Zven proteins and polynucleotides |
| 04/19/2007 | US20070087413 Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins |
| 04/19/2007 | US20070087409 Angiotensin peptide-carrier conjugates and uses thereof |
| 04/19/2007 | US20070087407 Hepatitis C receptor protein CD81 |
| 04/19/2007 | US20070087406 Isoforms of receptor for advanced glycation end products (RAGE) and methods of identifying and using same |
| 04/19/2007 | US20070087388 G protein coupled receptor |
| 04/19/2007 | US20070087379 Nucleotide sequences coding protein for use in the treatment of blood disorders; cDNA derived from mouse yolk sacs |
| 04/19/2007 | US20070087378 Polynucleotide and polypeptide fat metabolism regulators and uses thereof |
| 04/19/2007 | US20070087342 Secreted proteins |
| 04/19/2007 | US20070087054 Effervescent formulations of oxytocin |
| 04/19/2007 | US20070087047 Enhanced circulation effector composition and method |
| 04/19/2007 | US20070087032 Composition of cartilage therapeutic agents and its application |
| 04/19/2007 | US20070087029 Localized delivery to the lymphatic system |
| 04/19/2007 | US20070087024 Article comprising fibers embedded in a glassy protein |
| 04/19/2007 | US20070087016 Interleukin-12 as an adjuvant for paramyxoviridae vaccines |
| 04/19/2007 | US20070087007 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 04/19/2007 | US20070087003 Methods of treating a blood pathology using anti-TNF antibodies and fragments thereof |
| 04/19/2007 | US20070087001 phage display; fusion proteins; kits; immunohistochemistry |
| 04/19/2007 | US20070086993 Use of modified lysozyme c to prepare medicinal compositions for the treatment of some serious diseases |
| 04/19/2007 | US20070086992 stimulating antitumor immune responses; tissue-targeted therapy; first tumour antigen is used to treat secondary tumor; biodrug for cancer immunotherapy with cyclophosphamide |
| 04/19/2007 | US20070086991 Use of strains of lactobacillus and by-products thereof for inhibiting formation of blood vessels |
| 04/19/2007 | US20070086987 Skeletal musle-derived cells and methods related thereto |
| 04/19/2007 | US20070086985 Vectors for tissue-specific replication |
| 04/19/2007 | US20070086984 Viruses for the Treatment of Cellular Proliferative Disorders |
| 04/19/2007 | US20070086982 Gene therapy for regulating smooth muscle tone |
| 04/19/2007 | US20070086981 Delivery peptides, their constructs with active agents and use |
| 04/19/2007 | US20070086980 Methods of treating cancer using il-21 |
| 04/19/2007 | US20070086979 Methods and compositions for use in treatment of patients with autoantibody positive disease |
| 04/19/2007 | US20070086956 Method for accelerating the rate of mucociliary clearance |
| 04/19/2007 | US20070086952 Rapid Acting and Prolonged Acting Inhalable Insulin Preparations |
| 04/19/2007 | US20070086945 Preparations for diagnosis of pancreatic exocrine function |
| 04/19/2007 | DE102005049649A1 Composition, useful as e.g. nutritional supplement for the relief of gastro-intestinal tract complaints due to uptake of food containing oligosaccharide, comprises a combination of alpha-galactosidase and beta-fructofuraonosidase |
| 04/19/2007 | CA2626023A1 Modulators of nod1 signaling |
| 04/19/2007 | CA2625819A1 Leucine rich composition |
| 04/19/2007 | CA2625661A1 Synergistic pharmaceutical composition containing a peptide with 2 to 5 amino acids |
| 04/19/2007 | CA2625395A1 Vegf analogs and methods of use |
| 04/19/2007 | CA2625293A1 Fusion proteins for blood-brain barrier delivery |
| 04/19/2007 | CA2625206A1 Compstatin and analogs thereof for eye disorders |
| 04/19/2007 | CA2625150A1 Combined use of dpp-iv inhibitors and gastrin compounds |
| 04/19/2007 | CA2625091A1 Lysozyme fortified milk and milk products |
| 04/19/2007 | CA2625084A1 Pth formulations and methods of use |
| 04/19/2007 | CA2624990A1 Ckrox peptides and analogs thereof for treating skin ageing |
| 04/19/2007 | CA2624825A1 Tacrolimus combination products |
| 04/19/2007 | CA2624802A1 Latent procytotoxins and uses thereof |
| 04/19/2007 | CA2624673A1 Allele-specific rna interference |
| 04/19/2007 | CA2624531A1 Wwox gene, vectors containing the same, and uses in treatment of cancer |
| 04/19/2007 | CA2623563A1 Method of inhibiting angiogenesis by using ephrin b2 |
| 04/19/2007 | CA2623518A1 Method for treating or preventing ischemia reperfusion injury or multi-organ failure |
| 04/19/2007 | CA2622464A1 Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment |
| 04/19/2007 | CA2600201A1 Electromagnetic treatment apparatus for augmenting wound repair and method for using same |
| 04/18/2007 | EP1775346A1 Disulfide crosslinked glycoprotein hormone analogs, their preparation and use |
| 04/18/2007 | EP1775307A2 Bispecific antibody effective to treat B-cell lymphoma and cell line |
| 04/18/2007 | EP1775306A1 cKrox peptides and analogs thereof for treating skin ageing |
| 04/18/2007 | EP1774976A1 Malignant tumor local infiltration inhibitor containing batroxobin |
| 04/18/2007 | EP1774975A1 Use of human lysozyme in preparation of medicine for treating acne |
| 04/18/2007 | EP1774972A1 Use of selenium compounds, especially selenium yeasts in the treatment of Alzheimer, neurodegenerative diseases and diabetes |
| 04/18/2007 | EP1774332A2 Immune response assessment method |
| 04/18/2007 | EP1774329A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 04/18/2007 | EP1774326A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 2a receptor (5ht2a) |
| 04/18/2007 | EP1774001A2 Production of tissue factor in plants |
| 04/18/2007 | EP1773881A2 Inhibition of macrophage-stimulating protein receptor (ron) |
| 04/18/2007 | EP1773876A1 Hpv vaccine comprising peptides from host cell proteins |
| 04/18/2007 | EP1773871A2 Tdf-related compounds and analogs thereof |
| 04/18/2007 | EP1773868A1 Substituted prolines as inhibitors of hepatitis c virus ns3 serine protease |
| 04/18/2007 | EP1773867A2 Proteinaceous compounds and uses therefor |
| 04/18/2007 | EP1773864A1 Silk peptide improving neuroprotective and neurofunctional effects and a method of its preparation |
| 04/18/2007 | EP1773699A2 Napkin dispenser |
| 04/18/2007 | EP1773452A2 Lysis / resealing process and device for incorporating an active ingredient in erythrocytes |
| 04/18/2007 | EP1773397A2 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities |
| 04/18/2007 | EP1773395A2 A method for managing cholesterol with a serum-free and mitogen free cytokine mixture |
| 04/18/2007 | EP1773394A2 Antagonizing interleukin-21 receptor activity |
| 04/18/2007 | EP1773392A2 Method for preventing and treating mast cell mediated diseases |
| 04/18/2007 | EP1773386A2 Vaccine compositions and methods |
| 04/18/2007 | EP1773380A1 Hai-1 and hai-2 in cancer therapy |
| 04/18/2007 | EP1773379A2 Compositions and methods for dermatological wound healing |
| 04/18/2007 | EP1773378A2 Use of botulinum toxin for the preparation of a medicament for the treatment of lithiasis of salivary gland, gall bladder, kidney, or pancreas |
| 04/18/2007 | EP1773377A2 Food ingredients and food products treated with an oxidoreductase and methods for preparing such food ingredients and food products |
| 04/18/2007 | EP1773376A2 Antidiabetic oral insulin-biguanide combination |
| 04/18/2007 | EP1773375A1 Netrin-related compositions and uses |
| 04/18/2007 | EP1773374A1 An agent comprising fgf2 as an effective ingredient for treatment or prevention of asthma and chronic obstructive pulmonary disease |
| 04/18/2007 | EP1773373A2 Method for modulating, regulating and/or stabilizing angiogenesis |
| 04/18/2007 | EP1773372A2 Methods of preventing and treating alimentary mucositis |
| 04/18/2007 | EP1773371A2 Activated protein c inhibits undesirable effects of plasminogen activator in the brain |
| 04/18/2007 | EP1773370A1 Combination therapies employing platelet aggregation drugs |
| 04/18/2007 | EP1773369A1 Pharmaceutical compositions and methods for peptide treatment |
| 04/18/2007 | EP1773368A2 A method of pre-sensitizing cancer prior to treament with radiation and/or chemotherapy and a novel cytokine mixture |
| 04/18/2007 | EP1773367A2 Epidermal growth factor receptor antagonists and methods of use |
| 04/18/2007 | EP1773349A2 Methods and compositions for treatment of preeclampsia |
| 04/18/2007 | EP1773348A2 Tetrapeptide analogs |
| 04/18/2007 | EP1773331A1 Imidazole and thiazole derivatives as antiviral agents |
| 04/18/2007 | EP1773318A1 Combination anticancer therapy and pharmaceutical compositions therefor |
| 04/18/2007 | EP1773293A2 Compositions and methods for treating central precocious puberty |
| 04/18/2007 | EP1773240A2 Silk-based drug delivery system |
| 04/18/2007 | EP1773137A1 Anti-hypertensive functional food products |
| 04/18/2007 | EP1429817B1 Porous ceramic composite bone grafts |
| 04/18/2007 | EP1419174B1 Process for preparing glycopeptide derivatives |